An unknown healthcare investment firm acquired Substantially all of the assets of Infinity Pharmaceuticals, Inc. (OTCPK:INFI.Q) on February 15, 2024. Teresa C. Kohl, J. Scott Victor and Craig D. Warznak of SSG Capital Advisors, LLC served as the investment banker, George W. Shuster and Benjamin W. Loveland of Wilmer Cutler Pickering Hale and Dorr LLP, Matthew B. McGuire and Matthew R. Pierce of Landis Rath & Cobb LLP and Peter P. Knight, Mark D. Wood, Brian Sodikoff and Evan S. Borenstein of Katten Muchin Rosenman LLP acted as legal advisors, Matthew Foster and Scott Wiley of Sonoran Capital Advisors acted as financial advisor to Infinity Pharmaceuticals, Inc.

An undisclosed buyer completed the acquisition of Substantially all of the assets of Infinity Pharmaceuticals, Inc. (OTCPK:INFI.Q) on February 15, 2024.